R Squared Ltd Takes $100,000 Position in Cellebrite DI Ltd. (NASDAQ:CLBT)

R Squared Ltd purchased a new position in Cellebrite DI Ltd. (NASDAQ:CLBT) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 4,530 shares of the company’s stock, valued at approximately $100,000.

A number of other large investors also recently added to or reduced their stakes in the stock. FMR LLC increased its stake in shares of Cellebrite DI by 136.3% during the third quarter. FMR LLC now owns 5,616,757 shares of the company’s stock worth $94,586,000 after purchasing an additional 3,239,307 shares in the last quarter. Meitav Investment House Ltd. boosted its holdings in Cellebrite DI by 29.7% in the 3rd quarter. Meitav Investment House Ltd. now owns 2,066,322 shares of the company’s stock worth $34,797,000 after buying an additional 473,293 shares during the last quarter. Pembroke Management LTD increased its stake in Cellebrite DI by 24.3% during the 3rd quarter. Pembroke Management LTD now owns 1,908,345 shares of the company’s stock worth $32,137,000 after buying an additional 372,619 shares in the last quarter. Principal Financial Group Inc. acquired a new position in shares of Cellebrite DI during the third quarter valued at approximately $23,402,000. Finally, Two Sigma Advisers LP raised its holdings in shares of Cellebrite DI by 9.8% during the third quarter. Two Sigma Advisers LP now owns 1,341,100 shares of the company’s stock valued at $22,584,000 after acquiring an additional 120,000 shares during the last quarter. 45.88% of the stock is currently owned by institutional investors and hedge funds.

Cellebrite DI Stock Up 0.2 %

Shares of CLBT opened at $24.00 on Friday. The stock has a fifty day simple moving average of $21.61 and a two-hundred day simple moving average of $18.25. The company has a market capitalization of $4.94 billion, a PE ratio of -15.48, a price-to-earnings-growth ratio of 3.52 and a beta of 1.46. Cellebrite DI Ltd. has a 52-week low of $8.91 and a 52-week high of $24.62.

Cellebrite DI (NASDAQ:CLBT) last issued its earnings results on Wednesday, November 6th. The company reported $0.14 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.05. Cellebrite DI had a negative net margin of 82.28% and a positive return on equity of 122.59%. The company had revenue of $106.90 million for the quarter, compared to the consensus estimate of $102.06 million. During the same period in the previous year, the firm earned $0.09 earnings per share. Cellebrite DI’s quarterly revenue was up 27.0% compared to the same quarter last year. As a group, equities analysts anticipate that Cellebrite DI Ltd. will post 0.32 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently commented on CLBT. Craig Hallum boosted their price target on Cellebrite DI from $23.00 to $24.00 and gave the stock a “buy” rating in a research report on Thursday, November 7th. Needham & Company LLC upped their target price on shares of Cellebrite DI from $21.00 to $28.00 and gave the stock a “buy” rating in a report on Wednesday, January 22nd. Finally, JPMorgan Chase & Co. raised their price target on shares of Cellebrite DI from $22.00 to $24.00 and gave the stock an “overweight” rating in a research note on Monday, December 16th. Eight research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $21.57.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.